Reducing Disparities in Rural HIV Prevention
- Conditions
- HIV InfectionsSexually Transmitted Infections
- Interventions
- Other: Virtual clinical visits with home lab kits and mailed HIV PrEP
- Registration Number
- NCT05319613
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
HIV and Sexually Transmitted Infection (STI) rates are increasing in rural areas including rural Colorado. Many rural residents find it difficult to access HIV and STI prevention services.
In this study, an online survey on HIV and STI Prevention and best practices to provide access to prevention will be administered to rural residents in three zip 3 zones in rural Colorado. In addition to the baseline survey, study participants who are interested and medically eligible may initiate PrEP services with the University of Colorado HIV Prevention Program and receive PrEP through telemedicine visits, mailed home lab kits, and mailed medication. Persistence in PrEP care, acceptability, and feasibility of telemedicine and home lab kits will be measured.
- Detailed Description
HIV and Sexually Transmitted Infection (STI) rates are increasing in rural areas including rural Colorado. Many rural residents find it difficult to access HIV and STI prevention services. The goal of this study is to understand the risk for HIV and STIs, views on PrEP, and to determine if access to telemedicine visits and home lab kits increases engagement in PrEP services and persistence in care for at-risk rural populations.
An online survey on HIV and STI Prevention and best practices to provide access to prevention will be administered to rural residents in three zip 3 zones in rural Colorado, comprised of increased proportions of minority residents (Hispanic, Native American, and Black). In addition to the baseline survey, study participants who are interested and medically eligible may initiate PrEP services with the University of Colorado HIV Prevention Program and receive PrEP through telemedicine visits, mailed home lab kits, and mailed medication. Persistence in PrEP care, acceptability, and feasibility of telemedicine and home lab kits will be measured through baseline and follow-up survey questionnaires and clinical chart reviews for those engaged in PrEP care.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 69
- Colorado rural or frontier county residents, Adults (age 18+)
- Access to internet, smart phone or tablet to participate in online surveys
- Able to complete online surveys in English or Spanish
- Residence in an urban Colorado county
- HIV positive status
- No internet, smart phone, or tablet access
- Unable to complete online surveys in English or Spanish
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Telemedicine Clinical Care Virtual clinical visits with home lab kits and mailed HIV PrEP Rural participants who enter PrEP clinical care with University of Colorado HIV Prevention Program will receive care via telemedicine with mailed lab kits and mailed HIV PrEP.
- Primary Outcome Measures
Name Time Method Persistence in PrEP care 12 months The proportion of study participants persisting in PrEP care at 12 months, stratified by race, ethnicity, zip 3 region, and type of insurance coverage.
- Secondary Outcome Measures
Name Time Method Feasibility of postal lab kits 12 months Describe feasibility of postal lab kits, as determined by survey response and completion of quarterly lab monitoring.
Acceptability of Telemedicine visits 12 months Describe acceptability of Telemedicine visits as determined by survey response and completion of quarterly visits.
Feasibility of Telemedicine visits 12 months Describe feasibility of Telemedicine visits as determined by survey response and completion of quarterly visits.
Acceptability of postal lab kits 12 months Describe acceptability of postal lab kits, as determined by survey response and completion of quarterly lab monitoring.
Medication adherence 12 months Describe PrEP medication adherence rates at 12 months (as determined by pharmacy refill data) for rural CO PrEP users who utilize Telemedicine PrEP services and postal lab kits.
HIV seroconversion 12 months Describe rate of HIV seroconversion in cohort at 12 months.
Trial Locations
- Locations (1)
University of Colorado Hospital
🇺🇸Aurora, Colorado, United States